Cytomegaloviruses
- Human Cytomegalovirus Infections and Mechanisms of Disease
- Routes of Human CMV Transmission and Infection at the Uterine-Placental Interface
- Human Cytomegalovirus Genomics
- Manipulating Cytomegalovirus Genomes by BAC Mutagenesis:Strategies and Applications
- A Proteomics Analysis of Human Cytomegalovirus Particles
- Virus Entry and Activation of Innate Immunity
- Immediate Early Interactions and Epigenetic Defense Mechanisms
- Major Immediate-Early Enhancer and Its Gene Products
- Regulation of HCMV Gene Expression by Chromatin Remodelling
- Regulation of Viral mRNA Export from the Nucleus
- Exploitation of Host Cell Cycle Regulatory Pathways by HCMV
- Assembly and Maturation of the Capsid
- Glycoprotein Trafficking in Virion Morphogenesis
- Antibody-Mediated Neutralization of Infectivity
- Innate Immunity to Cytomegaloviruses
- Cytomegalovirus Interference with Interferons
- Adaptive Cellular Immunity to Human Cytomegalovirus
- Combat Between Cytomegalovirus and Dendritic Cells in T Cell Priming
- CD8 T Cell-Based Immunotherapy of Cytomegalovirus Disease in the Mouse Model of the Immunocompromised Bone Marrow Transplantation Recipient
- Determinants of Macrophage Tropism
- Determinants of Endothelial Cell Tropism of Human Cytomegalovirus
- Myeloid Cell Recruitment and Function in Pathogenesis and Latency
- Murine Model of Cytomegalovirus Latency and Reactivation: The Silencing/Desilencing and Immune Sensing Hypothesis
- The Rat Model for CMV Infection and Vascular Disease
- The Guinea Pig Model of Congenital Cytomegalovirus Infection
- Current Perspectives in Vaccine Development
- Antiviral Intervention, Resistance and Perspectives
- Primate Models: Pros and Cons
- Cytomegaloviruses